Onderneming Bristol-Myers Squibb Company Sao Paulo
Aandelen
BMYB34
BRBMYBBDR000
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
229,5 BRL | 0,00% | +3,49% | -8,15% |
Vakgebied
De Verenigde Staten zijn goed voor 70,1% van de netto-omzet.
Aantal werknemers: 34 100
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 46 159 | 100,0 % | 45 006 | 100,0 % | -2,50% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
70,1
%
| 31 828 | 69,0 % | 31 555 | 70,1 % | -0,86% |
International
28,3
%
| 13 497 | 29,2 % | 12 752 | 28,3 % | -5,52% |
Other
1,6
%
| 834 | 1,8 % | 699 | 1,6 % | -16,19% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 53 | 01-02-15 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 01-01-03 | |
Chief Tech/Sci/R&D Officer | - | - | |
Samit Hirawat
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-19 |
Robert Plenge
CTO | Chief Tech/Sci/R&D Officer | 53 | 01-11-19 |
Laura Hortas
IRO | Public Communications Contact | - | - |
Corporate Officer/Principal | - | - | |
Cari Gallman
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 20-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 01-04-16 |
Derica Rice
BRD | Director/Board Member | 59 | 01-09-20 |
Paula Price
BRD | Director/Board Member | 62 | 01-09-20 |
Theodore Samuels
BRD | Director/Board Member | 69 | 21-02-17 |
David Elkins
DFI | Director of Finance/CFO | 55 | 20-11-19 |
Chief Executive Officer | 53 | 01-02-15 | |
Julia Haller
BRD | Director/Board Member | 69 | 20-11-19 |
Deepak Bhatt
BRD | Director/Board Member | 56 | 14-06-22 |
Karen Vousden
BRD | Director/Board Member | 66 | 01-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 923 100 096 | 2 024 937 138 ( 69,27 %) | 896 000 000 ( 30,65 %) | 69,27 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
5 075 304 | 6.37% | 120 944 494 $ | |
KURA ONCOLOGY, INC. 1.80% | 1 370 171 | 1.80% | 26 033 249 $ |
KURA ONCOLOGY, INC. 6.36% | 759 145 | 6.36% | 21 438 255 $ |
COMPUGEN LTD. 5.31% | 4 757 058 | 5.31% | 9 546 749 $ |
CELULARITY INC. 5.49% | 1 195 327 | 5.49% | 3 669 654 $ |
Bedrijfsgegevens
Bristol Myers Squibb Co.
Route 206 & Province Line Road
08543, Princeton
+609 252 4621
http://www.bms.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Bristol-Myers Squibb India Pvt Ltd.
Bristol-Myers Squibb India Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb India Pvt Ltd. discovers, develops and delivers medicines for immuno-oncology. The private company is based in Mumbai, India. |
Pharmaceuticals: Major
|
Bristol-Myers Squibb de México S de RL de CV
Bristol-Myers Squibb de México S de RL de CV Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb de México S de RL de CV is a Mexican company that manufactures and supplies pharmaceutical and nutritional products. The private company is located in Mexico. |
Pharmaceuticals: Major
|
Celgene Kappa Holdings LLC
| |
Bristol-Myers Squibb International Co. ULC
| |
Bristol-Myers Squibb Holdings Germany Verwaltungs GmbH
| |
Seamair Insurance DAC
| |
Bristol-Myers Squibb AE
| |
Swords Laboratories Unlimited Co.
Swords Laboratories Unlimited Co. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Swords Laboratories Unlimited Co. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Swords, Ireland. |
Pharmaceuticals: Major
|
BMS Strategic Portfolio Investments Holdings, Inc.
|
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,60% | 364 mld. | |
+20,83% | 326 mld. | |
+5,69% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+10,77% | 167 mld. | |
+0,10% | 161 mld. |
- Beurs
- Aandelen
- Koers BMY
- Koers BMYB34
- Onderneming Bristol-Myers Squibb Company